Potential use of serum‐derived bovine immunoglobulin/protein isolate for the management of COVID‐19

COVID‐19 manifests as a mild disease in most people but can progress to severe disease in nearly 20% of individuals. Disease progression is likely driven by a cytokine storm, either directly stimulated by SARS‐CoV‐2 or by increased systemic inflammation in which the gut might play an integral role....

Descripción completa

Detalles Bibliográficos
Autores principales: Utay, Netanya S., Asmuth, David M., Gharakhanian, Shahin, Contreras, Moises, Warner, Christopher D., Detzel, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293029/
https://www.ncbi.nlm.nih.gov/pubmed/34110032
http://dx.doi.org/10.1002/ddr.21841

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293029/
https://www.ncbi.nlm.nih.gov/pubmed/34110032
http://dx.doi.org/10.1002/ddr.21841

Ejemplares similares